L. Agence-de and . Biomédecine, Le rapport médical et scientifique du prélèvement et de la greffe en France, 2011.

L. Agence-de and . Biomédecine, Rapport annuel 2012 de l'Agence de la biomédecine, 2012.

A. Abbas and A. Lichtman, Réponse immunitaire de type cellulaire -Activation des lymphocytes T. Les bases de l'immunologie fondamentale et clinique, pp.81-102

O. Thaunat and E. Morelon, Mode d'action des immunosuppresseurs et leurs complications

C. Lefaucheur, A. Loupy, D. Vernerey, J. Duong-van-huyen, C. Suberbielle et al., Antibody-mediated vascular rejection of kidney allografts: a population-based study, The Lancet, vol.381, issue.9863, pp.313-319, 2013.
DOI : 10.1016/S0140-6736(12)61265-3

J. Fishman, Infection in Solid-Organ Transplant Recipients, New England Journal of Medicine, vol.357, issue.25, pp.2601-2614, 2007.
DOI : 10.1056/NEJMra064928

C. Kotton and J. Fishman, Viral Infection in the Renal Transplant Recipient, Journal of the American Society of Nephrology, vol.16, issue.6, pp.1758-1774, 2005.
DOI : 10.1681/ASN.2004121113

S. Juan, R. Aguado, J. Lumbreras, C. Díaz-pedroche, C. López-medrano et al., Incidence, Clinical Characteristics and Risk Factors of Late Infection in Solid Organ Transplant Recipients: Data from the RESITRA Study Group, :964?971. 10. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside, 2007.
DOI : 10.1097/00007890-200205270-00013

S. Lopo, E. Vinagre, P. Palminha, M. Paixao, P. Nogueira et al., Seroprevalence to cytomegalovirus in the Portuguese population, Euro Surveill, vol.16, 2002.

S. Bate, S. Dollard, and M. Cannon, Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988???2004, Clinical Infectious Diseases, vol.50, issue.11, pp.1439-1447, 1988.
DOI : 10.1086/652438

I. Helanterä, I. Lautenschlager, P. Koskinen, C. Kotton, D. Kumar et al., The risk of cytomegalovirus recurrence after kidney transplantation International consensus guidelines on the management of cytomegalovirus in solid organ transplantation Extended valganciclovir prophylaxis in D+/R-kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation, Transpl Int. déc Transplantation. avr Transplantation. déc Am J Transplant. janv, vol.2489908, pp.1427-1431, 2008.

O. Witzke, I. Hauser, M. Bartels, G. Wolf, H. Wolters et al., Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients, Transplantation
DOI : 10.1097/TP.0000000000002024

A. Sylwester, B. Mitchell, J. Edgar, C. Taormina, C. Pelte et al., Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects Functional signatures of protective antiviral T-cell immunity in human virus infections Van de Berg PJEJ, van Stijn A, Ten Berge IJM, van Lier RAW. A fingerprint left by cytomegalovirus infection in the human T cell compartment Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion, Transplantation. janv J Exp Med. sept Immunol Rev. juin J Clin Virol. mars Villacres MC Hum Immunol. mai, vol.932022114165, issue.20, pp.61-68, 2004.

V. Appay, R. Van-lier, F. Sallusto, M. Roederer, K. Mckinstry et al., Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytom A Expanding roles for CD4 + T cells in immunity to viruses, nov Nat Rev Immunol. févr, vol.7312, pp.136-148, 2008.

L. Gattinoni, E. Lugli, Y. Ji, Z. Pos, C. Paulos et al., A human memory T cell subset with stem cell-like properties1290?1297. 26. Pantaleo G, Harari A. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases, Nat Med. oct Nat Rev Immunol. mai, vol.176, pp.417-423, 2006.

C. Riou, F. Treurnicht, M. Abrahams, K. Mlisana, M. Liu et al., Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for cytomegalovirus-specific CD8+ T cells Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation, J Immunol. oct Am J Transplant. nov, vol.18911, pp.2463-2471, 2011.

T. Bunde, A. Kirchner, B. Hoffmeister, D. Habedank, R. Hetzer et al., Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells High levels of CMV-IE-1- specific memory T cells are associated with less alloimmunity and improved renal allograft function, J Exp Med. avr Transpl Immunol. mars, vol.20120, 2005.

M. Ladriere, Y. Foucher, C. Legendre, N. Kamar, V. Garrigue et al., The Western Europe Cohort of Kidney Transplanted Recipients-The DIVAT Network. 33 Evaluating cellular polyfunctionality with a novel polyfunctionality index, PloS One. Béné MC, vol.7, issue.34, 2012.

M. Betjes, A. Langerak, A. Van-der-spek, E. De-wit, N. Litjens et al., Premature aging of circulating T cells in patients with end-stage renal disease Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age Expansion of cytolytic CD4+CD28-T cells in end-stage renal disease Cyclosporin A and tacrolimus reduce T-cell polyfunctionality but not interferon-? responses directed at cytomegalovirus, Automated cell count in flow cytometry: a valuable tool to assess CD4 absolute levels in peripheral blood408?413. 40. Havenith SHC, Yong SL, van Donselaar-van der Pant KAMI, van Lier RAW, ten Berge IJM, Bemelman FJ. Everolimus-treated renal transplant recipients have a more robust CMVspecific CD8+ T-cell response compared with cyclosporine-or mycophenolate-treated patients. Transplantation. 15 janv, pp.208-217, 1998.

C. Réact, Receveurs séropositifs pour le CMV avec réactivation virale ; No Réact : Receveurs séropositifs pour le CMV sans réactivation virale ; TN : Lymphocytes T naïfs